Form 4 for ACAD ACADIA PHARMACEUTICALS INC
Accepted 2025-03-26 00:00:00 ET · period of report 2025-03-24 · accession 0001415889-25-009074 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-03-26 | 2025-03-25 | ACAD | Schneyer Mark C. | EVP, CFO | M - OptEx | — | +6,178 | 60.1K | +11% | — |
| D | 2025-03-26 | 2025-03-26 | ACAD | Schneyer Mark C. | EVP, CFO | S - Sale+OE | $17.05 | -3,171 | 56.9K | -5% | -$54.1K |
| D | 2025-03-26 | 2025-03-25 | ACAD | Schneyer Mark C. | EVP, CFO | M - OptEx | $0.00 | -6,178 | 18.5K | -25% | $0 |
| DM | 2025-03-26 | 2025-03-24 | ACAD | Schneyer Mark C. | EVP, CFO | A - Grant | $0.00 | +143.3K | 32.6K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-03-25 | M | A | 6,178 | — | 60,060 | D | — | — | (F1) Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. |
| 2 | Common | Common Stock | 2025-03-26 | S | D | 3,171 | $17.05 | 56,889 | D | — | — | |
| 3 | Derivative | Restricted Stock Units | 2025-03-25 | M | D | 6,178 | $0.00 | 18,536 | D | — · — to — | 6,178 Common Stock | (F1) Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. (F5) The restricted stock units vest in four equal annual installments beginning March 25, 2025. |
| 4 | Derivative | Stock Option (Right to Buy) | 2025-03-24 | A | A | 110,761 | $0.00 | 110,761 | D | $17.23 · — to 2035-03-23 | 110,761 Common Stock | (F3) 25% of the shares subject to the Stock Option will vest and become exercisable on March 24, 2026. The remaining shares vest and become exercisable in 36 equal monthly installments thereafter. |
| 5 | Derivative | Restricted Stock Units | 2025-03-24 | A | A | 32,552 | $0.00 | 32,552 | D | — · — to — | 32,552 Common Stock | (F1) Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. (F4) The restricted stock units vest in four equal annual installments beginning March 24, 2026. |